CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleMarket cap is $2.36B, above the global median of $1.15B
- Interpretations2 currently firing — 2
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
2.36BUSDvs all stocks (USD)
Revenue (TTM)
885.72MUSDvs all stocks (USD)
Profit Margin
-51.71%Beta
0.5430xvs all stocks
52-Week Change
9.04%vs all stocks
Market Capitalization
2.36BUSDvs all stocks (USD)
Enterprise Value
3.01BUSDvs all stocks (USD)
Forward P/E
9.84xPrice to Sales (TTM)
2.61xEnterprise to Revenue
3.40xEnterprise to EBITDA
9.22xGross Margin
96.56%Profit Margin
-51.71%Operating Margin
-2.45%Return on Assets (TTM)
42.62%Revenue (TTM)
885.72MUSDvs all stocks (USD)
Revenue per Share (TTM)
4.06USDUpdated Jul 18, 2026Quarterly Revenue Growth
7.50%Gross Profit (TTM)
678.70MUSDvs all stocks (USD)
EBITDA (TTM)
365.14MUSDvs all stocks (USD)
Net Income (TTM)
-457.98MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
7.48%Operating Cash Flow (TTM)
313.10MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
264.38MUSDvs all stocks (USD)
Payout Ratio
0.00%Revenue
874.84MUSDFY2025 · Dec 31, 2025Cost of Goods Sold
19.07MUSDFY2025 · Dec 31, 2025Gross Profit
855.76MUSDFY2025 · Dec 31, 2025Operating Income
340.99MUSDvs all stocks (USD)
Pre-tax Income
267.39MUSDFY2025 · Dec 31, 2025Income Tax Expense
3.53MUSDFY2025 · Dec 31, 2025Net Income
263.86MUSDFY2025 · Dec 31, 2025EBIT
346.26MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
365.14MUSDFY2025 · Dec 31, 2025Research & Development
166.13MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
348.65MUSDFY2025 · Dec 31, 2025Non-operating Interest Income
10.67MUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
78.87MUSDFY2025 · Dec 31, 2025EPS (Basic)
1.26USDFY2025 · Dec 31, 2025EPS (Diluted)
1.21USDFY2025 · Dec 31, 2025Basic Shares Outstanding
209.89MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
209.89MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
263.86MUSDFY2025 · Dec 31, 2025Operating Cash Flow
327.78MUSDFY2025 · Dec 31, 2025Free Cash Flow
325.31MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
91.34MUSDFY2025 · Dec 31, 2025Interest Paid
23.73MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
263.86MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
1.39MUSDFY2025 · Dec 31, 2025Stock-based Compensation
80.75MUSDFY2025 · Dec 31, 2025Other Non-cash Items
30.85MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-36.81MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
57.80MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-70.07MUSDFY2025 · Dec 31, 2025Capital Expenditures
-2.47MUSDFY2025 · Dec 31, 2025Net Acquisitions
-6.18MUSDFY2025 · Dec 31, 2025Purchase of Investments
-262.24MUSDFY2025 · Dec 31, 2025Sale of Investments
256.65MUSDFY2025 · Dec 31, 2025Other Investing Activity
550.00KUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
-13.69MUSDFY2025 · Dec 31, 2025Long-term Debt Issuance
0.00USDFY2025 · Dec 31, 2025Long-term Debt Payments
-301.99MUSDFY2025 · Dec 31, 2025Other Financing Charges
-57.12MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
-359.05MUSDFY2025 · Dec 31, 2025Shares Outstanding
254.01MSharesUpdated Jul 18, 2026Float Shares
221.04MSharesUpdated Jul 18, 2026Shares Short
48.69MSharesUpdated Jul 18, 2026Short Ratio
8.38daysvs all stocks
Short % of Shares Outstanding
19.30%vs all stocks
% Held by Insiders
1.20%vs all stocks
% Held by Institutions
100.25%vs all stocks
Total Cash (MRQ)
238.40MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
0.9380USDUpdated Jul 18, 2026Total Debt (MRQ)
858.08MUSDvs all stocks (USD)
Current Ratio (MRQ)
1.91xBook Value per Share (MRQ)
-2.18USDUpdated Jul 18, 2026Total Assets
514.16MUSDvs all stocks (USD)
Total Current Assets
404.35MUSDFY2025 · Dec 31, 2025Total Liabilities
633.31MUSDFY2025 · Dec 31, 2025Total Non-current Assets
109.81MUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
437.25MUSDFY2025 · Dec 31, 2025Total Current Liabilities
196.07MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
89.74MUSDFY2025 · Dec 31, 2025Other Short-term Investments
185.01MUSDFY2025 · Dec 31, 2025Accounts Receivable
106.82MUSDFY2025 · Dec 31, 2025Inventory
5.40MUSDFY2025 · Dec 31, 2025Accounts Payable
15.83MUSDFY2025 · Dec 31, 2025Short-term Debt
1.63MUSDFY2025 · Dec 31, 2025Other Current Liabilities
52.20MUSDFY2025 · Dec 31, 2025Long-term Debt
437.25MUSDFY2025 · Dec 31, 2025Common Stock (Book)
2.13MUSDFY2025 · Dec 31, 2025Retained Earnings
-1.51BUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
-119.15MUSDvs all stocks (USD)
52-Week Low
6.00USDUpdated Jul 18, 202652-Week High
11.22USDUpdated Jul 18, 202652-Week Change
9.04%vs all stocks
Beta
0.5430xvs all stocks
50-Day MA
9.18USDUpdated Jul 18, 2026200-Day MA
8.11USDUpdated Jul 18, 2026Avg 10-Day Volume
4.90MSharesUpdated Jul 18, 2026Avg 30-Day Volume
5.61MSharesUpdated Jul 18, 2026Diluted EPS (TTM)
-1.77USDUpdated Jul 18, 2026Other Income / Expense
-5.39MUSDFY2025 · Dec 31, 20252 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Operating Income Growing With Multi-Year Revenue Growth
Revenue up in each of five years, with operating income up in each of four.
Reads
Is this company growing?
Revenue Growth With Elevated Margin
Revenue up in each of five years, while its operating margin stays high.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.97Profit Margin: -0.52
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Market cap is $2.36B, above the global median of $1.15BNotable
Market cap (USD): 2,361,171,111Global Median: 1,146,734,693.424
Revenue is $885.72M, above the global median of $520.53MNotable
Revenue (USD): 885,715,968Global Median: 520,528,949.311
Levered free cash flow is $264.38M, above the global median of $16.24MNotable
Levered free cash flow (USD): 264,383,248Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Prestige Consumer Healthcare Inc.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Pell Bio-Med Technology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
BrightGene Bio-Medical Technology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Vericel Corporation
Tier 1ProductionApproval-Gated PipelineRule
Mineralys Therapeutics, Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Biohaven Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Nurix Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Nektar Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Agios Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Companies that share active interpretations — structural patterns currently present in both stocks.
Aurinia Pharmaceuticals Inc.
2 interpretationsRevenue Growth With Elevated MarginOperating Income Growing With Multi-Year Revenue Growth
Wuhan Dameng Database Co., Ltd.
2 interpretationsRevenue Growth With Elevated MarginOperating Income Growing With Multi-Year Revenue Growth
Sanil Electric Co. Ltd.
2 interpretationsRevenue Growth With Elevated MarginOperating Income Growing With Multi-Year Revenue Growth